[Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
D001262:Atenolol / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D009638:Norepinephrine / Q000097:blood; D011187:Posture; D011412:Propanolamines / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D012083:Renin / Q000097:blood; D014223:Triamterene / Q000627:therapeutic use*
D004338:Drug Combinations; D011412:Propanolamines; D006852:Hydrochlorothiazide; D001262:Atenolol; D012083:Renin; D014223:Triamterene; D009638:Norepinephrine
Crossover-Studie über Therapieindikatoren und blutdrucksenkende Wirkung des beta-Rezeptorenblockers Atenolol und der Diuretikakombination Triamteren/Hydrochlorothiazid.